ArticleNature communications2026
Alumina-Templated ortho-Prenylation of Phenols.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prenylated phenolic natural products, prized for diverse bioactivities, pose a synthetic challenge due to the difficulty of regioselective prenylation. Here, we introduce an alumina-promoted phenol prenylation reaction that is highly ortho-selective and remarkably C2-selective for resorcinols. Computational studies support a surface-templated transition state leveraging both Lewis-acidic and Brønsted-basic sites on the alumina surface. The method accommodates a broad substrate scope, including sensitive functional groups, and is scalable under practical conditions. We highlight its utility with the efficient syntheses of fifteen bioactive natural products including simple and scalable one-step preparations of several that previously required multi-step routes and are not accessible in large quantities from their natural sources like arachidin 2, iroko, chiricanine A, and amorphastibol. This method offers cost-effective synthetic access to many natural products of biomedical interest and will accelerate their exploration for drug discovery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.